Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 

Thumbnail

How early marijuana use affects the heart later in life

Researchers used ultrasound imaging to examine the hearts of young adults who smoked marijuana and those who did not. Their full analysis was published in the Journal of Applied Physiology

Thumbnail

New research points to a better strategy for cardiovascular risk assessment

The team sees significant potential in its findings, though they still hope to make the technique "simpler and more clinically implementable."

Johnson & Johnson COVID-19 vaccine being investigated for possible blood clot risk

The European Medicines Agency is investigating the issue with help from the FDA. At this stage, the group emphasized that it remains unclear if the Johnson & Johnson vaccine is associated with any specific blood clot risk.

Abbott’s next-generation device for tricuspid heart valve repair gains CE mark approval

The device is only approved in the United States for investigational use at this time.

Thumbnail

Uninterrupted OAC therapy for PCI patients leads to cost savings, shorter lengths of stay

Putting OAC therapy on hold does have its own benefits, the authors wrote, but uninterrupted OAC therapy is still the better choice. 

Radiologists’ public service message underscores need to educate patients on COVID-19 vaccine side effects

Physicians called on imaging societies, clinicians and news media to spread awareness about vaccine-related swollen lymph nodes.

Thumbnail

Metformin shows promise for treating polycystic kidney disease

Typically used to treat Type 2 diabetes, metformin may also provide value as a treatment option for a serious, potentially fatal kidney disease.